^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
Stockholm3

Type:
Laboratory Developed Test

Details

Evidence
News
Twitter
Stockholm3 is a blood test for early detection of aggressive prostate cancer. The test combines protein markers, genetic markers and clinical data in a proprietary algorithm for the purpose of detecting aggressive prostate cancer at an early stage. The result from Stockholm3 is a risk score that indicates the risk of aggressive prostate cancer and a recommendation that describes continued treatment.
Cancer:
Prostate Cancer